Abstract:Protein degradation is essential for maintaining protein homeostasis. The ubiquitin‒proteasome system (UPS) and autophagy–lysosome system are the two primary pathways responsible for protein degradation and directly related to cell survival. In malignant tumors, the UPS plays a critical role in managing the excessive protein load caused by cancer cells hyperproliferation. In this review, we provide a comprehensive overview of the dual roles played by the UPS and autolysosome system in colorectal cancer (CRC), elucidating their impact on the initiation and progression of this disease while also highlighting their compensatory relationship. Simultaneously targeting both protein degradation pathways offers new promise for enhancing treatment efficacy against CRC. Additionally, apoptosis is closely linked to ubiquitination and autophagy, and caspases degrade proteins. A thorough comprehension of the interplay between various protein degradation pathways is highly important for clarifying the mechanism underlying the onset and progression of CRC.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the role and mechanism of the protein degradation system in colorectal cancer (CRC). Specifically, the paper explores the dual roles of the ubiquitin - proteasome system (UPS) and the autophagy - lysosome system in maintaining protein homeostasis, as well as their impact on the occurrence and development of CRC. In addition, the paper also explores the compensatory relationship between these two systems and proposes new treatment strategies targeting both protein degradation pathways simultaneously to improve the treatment effect of CRC. ### Main problem points of the paper: 1. **Regulatory mechanisms of UPS and autophagy - lysosome system**: The paper explores how these two systems maintain protein homeostasis in normal cells and how these balances are disrupted in malignant tumors. 2. **Selection factors of protein degradation pathways in CRC**: It studies how specific factors or signaling pathways determine the priority use of UPS or autophagy - lysosome system for protein degradation in CRC. 3. **Impact of protein degradation pathway dysregulation on CRC development**: It explores how the dysregulation of UPS and autophagy - lysosome system affects the initiation, growth, and metastasis of CRC. 4. **Compensatory relationship and treatment strategies**: It studies the compensatory relationship between UPS and autophagy - lysosome system in CRC and whether simultaneously targeting these two pathways can effectively overcome the adaptive response and drug - resistance mechanism of cancer cells to single - pathway inhibition. 5. **Drug tolerance and tumor progression**: It explores how the dysregulation of UPS and autophagy - lysosome system leads to drug tolerance acquisition and tumor progression in CRC. 6. **Potential treatment strategies**: It proposes possible treatment strategies or combination therapies to enhance the treatment effect and improve the prognosis of patients by regulating protein degradation pathways. ### Detailed exploration of specific problems: - **Molecular mechanism**: It explores how the balance between UPS and autophagy - lysosome system maintaining protein homeostasis in normal cells is broken, especially in malignant tumors. - **Selection factors**: It studies how specific factors or signaling pathways determine the priority use of UPS or autophagy - lysosome system for protein degradation in CRC. - **Impact of dysregulation**: It analyzes how the dysregulation of UPS and autophagy - lysosome system affects the development of CRC, including tumor initiation, growth, and metastasis. - **Compensatory relationship**: It studies the compensatory relationship between UPS and autophagy - lysosome system in CRC and how this relationship affects the treatment effect. - **Drug - resistance mechanism**: It explores how the dysregulation of UPS and autophagy - lysosome system leads to drug tolerance acquisition and tumor progression in CRC. - **Treatment strategies**: It proposes possible treatment strategies or combination therapies to enhance the treatment effect and improve the prognosis of patients by simultaneously targeting UPS and autophagy - lysosome system. Through the exploration of these problems, the paper aims to provide a more solid theoretical basis for understanding the occurrence and development of CRC and provide a scientific basis for new treatment strategies.

Role of protein degradation systems in colorectal cancer

Interplay Between Apoptosis and Autophagy in Colorectal Cancer

The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors

Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review

Protein degradation: expanding the toolbox to restrain cancer drug resistance

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention

Roles of Ubiquitination in the Crosstalk Between Tumors and the Tumor Microenvironment (Review)

Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway

Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress

Roles of deubiquitinases in urologic cancers (Review)

Navigating therapeutic prospects by modulating autophagy in colorectal cancer

Different Roles of Apoptosis and Autophagy in the Development of Human Colorectal Cancer

Molecular mechanisms and functions of autophagy and the ubiquitin-proteasome pathway]

Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players

Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment

Comprehensive Analysis Reveals the Potential Regulatory Mechanism Between Ub–Proteasome System and Cell Cycle in Colorectal Cancer

Autophagy and Its Role in Colorectal Pathogenesis and Treatment

The role of ubiquitination in health and disease

Protein Post-Translational Modifications: A Key Factor in Colorectal Cancer Resistance Mechanisms.

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy.